Dean Destructo
New member
J Sex Med. 2006 Jan;3(1):104-13.
[h=1]Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction.[/h]Panzer C1, Wise S, Fantini G, Kang D, Munarriz R, Guay A, Goldstein I.
[h=3]Author information[/h]
[h=3]Abstract[/h][h=4]INTRODUCTION:[/h]<abstracttext label="INTRODUCTION" nlmcategory="BACKGROUND">Oral contraceptives (OCs) have been the preferred method of birth controlbecause of their high rate of effectiveness. OC use, however, has been associated with women's sexual health complaints and androgen insufficiency. OC use is associated with a decrease of androgen ovarian synthesis and an increase in the production of sex hormone-binding globulin (SHBG). There have been limited studies assessing SHBG values after discontinuation of OC use.</abstracttext>
[h=4]AIM:[/h]<abstracttext label="AIM" nlmcategory="OBJECTIVE">To retrospectively investigate SHBG levels before and after discontinuation of OC use.</abstracttext>
[h=4]MAIN OUTCOME MEASURE:[/h]<abstracttext label="MAIN OUTCOME MEASURE" nlmcategory="METHODS">Sex hormone-binding globulin values were compared at baseline, while on the OC, and well beyond the 7-day half-life of SHBG at 49-120 (mean 80) days and >120 (mean 196) days after discontinuation of OCs.</abstracttext>
[h=4]METHODS:[/h]<abstracttext label="METHODS" nlmcategory="METHODS">A total of 124 premenopausal women with sexual health complaints for >6 months met inclusion/exclusion criteria. Three groups of women were defined: (i) "Continued-Users" (N = 62; mean age 32 years) had been on OCs for >6 months and continued taking them; (ii) "Discontinued-Users" (N = 39; mean age 33 years) had been on OCs for >6 months anddiscontinued them; and (iii) "Never-Users" (N = 23; mean age 36 years) had never taken OCs.</abstracttext>
[h=4]RESULTS:[/h]<abstracttext label="RESULTS" nlmcategory="RESULTS">Sex hormone-binding globulin values in the "Continued-Users" were four times higher than those in the "Never-User" group (mean 157 +/- 13 nmol/L vs. 41 +/- 4 nmol/L; P < 0.0001). Despite a decrease in SHBG values after discontinuation of OC use, SHBG levels in "Discontinued-Users" remained elevated in comparison with "Never-Users" (N = 26; P < 0.0001 for >120 days).</abstracttext>
[h=4]CONCLUSION:[/h]<abstracttext label="CONCLUSION" nlmcategory="CONCLUSIONS">In women with sexual dysfunction, SHBG changes in "Discontinued-Users" did not decrease to values consistent with "Never-Users." Long-term sexual, metabolic, and mental health consequences might result as a consequence of chronic SHBG elevation. Does prolonged exposure to the synthetic estrogens of OCs induce gene imprinting and increased gene expression of SHBG in the liver in some women? Prospective research is needed.</abstracttext>
[h=3]Comment in[/h]
<dl class="rprtid" style="margin-right: 15px; margin-left: 0px; font-size: 0.8465em; line-height: 1.4em; display: inline;"><dt style="display: inline; padding: 0px; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px !important; white-space: nowrap;">PMID:</dt> <dd style="margin: 0px; display: inline; padding: 0px; white-space: nowrap;">16409223</dd> <dd style="margin: 0px; display: inline; padding: 0px; white-space: nowrap;">[PubMed - indexed for MEDLINE]</dd><dd style="margin: 0px; display: inline; padding: 0px; white-space: nowrap;"></dd></dl>
[h=1]Impact of oral contraceptives on sex hormone-binding globulin and androgen levels: a retrospective study in women with sexual dysfunction.[/h]Panzer C1, Wise S, Fantini G, Kang D, Munarriz R, Guay A, Goldstein I.
[h=3]Author information[/h]
[h=3]Abstract[/h][h=4]INTRODUCTION:[/h]<abstracttext label="INTRODUCTION" nlmcategory="BACKGROUND">Oral contraceptives (OCs) have been the preferred method of birth controlbecause of their high rate of effectiveness. OC use, however, has been associated with women's sexual health complaints and androgen insufficiency. OC use is associated with a decrease of androgen ovarian synthesis and an increase in the production of sex hormone-binding globulin (SHBG). There have been limited studies assessing SHBG values after discontinuation of OC use.</abstracttext>
[h=4]AIM:[/h]<abstracttext label="AIM" nlmcategory="OBJECTIVE">To retrospectively investigate SHBG levels before and after discontinuation of OC use.</abstracttext>
[h=4]MAIN OUTCOME MEASURE:[/h]<abstracttext label="MAIN OUTCOME MEASURE" nlmcategory="METHODS">Sex hormone-binding globulin values were compared at baseline, while on the OC, and well beyond the 7-day half-life of SHBG at 49-120 (mean 80) days and >120 (mean 196) days after discontinuation of OCs.</abstracttext>
[h=4]METHODS:[/h]<abstracttext label="METHODS" nlmcategory="METHODS">A total of 124 premenopausal women with sexual health complaints for >6 months met inclusion/exclusion criteria. Three groups of women were defined: (i) "Continued-Users" (N = 62; mean age 32 years) had been on OCs for >6 months and continued taking them; (ii) "Discontinued-Users" (N = 39; mean age 33 years) had been on OCs for >6 months anddiscontinued them; and (iii) "Never-Users" (N = 23; mean age 36 years) had never taken OCs.</abstracttext>
[h=4]RESULTS:[/h]<abstracttext label="RESULTS" nlmcategory="RESULTS">Sex hormone-binding globulin values in the "Continued-Users" were four times higher than those in the "Never-User" group (mean 157 +/- 13 nmol/L vs. 41 +/- 4 nmol/L; P < 0.0001). Despite a decrease in SHBG values after discontinuation of OC use, SHBG levels in "Discontinued-Users" remained elevated in comparison with "Never-Users" (N = 26; P < 0.0001 for >120 days).</abstracttext>
[h=4]CONCLUSION:[/h]<abstracttext label="CONCLUSION" nlmcategory="CONCLUSIONS">In women with sexual dysfunction, SHBG changes in "Discontinued-Users" did not decrease to values consistent with "Never-Users." Long-term sexual, metabolic, and mental health consequences might result as a consequence of chronic SHBG elevation. Does prolonged exposure to the synthetic estrogens of OCs induce gene imprinting and increased gene expression of SHBG in the liver in some women? Prospective research is needed.</abstracttext>
[h=3]Comment in[/h]
<dl class="rprtid" style="margin-right: 15px; margin-left: 0px; font-size: 0.8465em; line-height: 1.4em; display: inline;"><dt style="display: inline; padding: 0px; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px !important; white-space: nowrap;">PMID:</dt> <dd style="margin: 0px; display: inline; padding: 0px; white-space: nowrap;">16409223</dd> <dd style="margin: 0px; display: inline; padding: 0px; white-space: nowrap;">[PubMed - indexed for MEDLINE]</dd><dd style="margin: 0px; display: inline; padding: 0px; white-space: nowrap;"></dd></dl>
- <button data-share="Facebook" title="Share on Facebook" class="share_facebook" ref="id=16409223&db=pubmed" style="font-family: inherit; font-size: 13px; margin: 2px 2px 2px 0em; cursor: pointer; border: 0px none; height: 16px; padding: 2px; text-indent: -999em; width: 16px; opacity: 0.5; transition: opacity 0.2s linear 0s; background-image: url("//static.pubmed.gov/portal/portal3rc.fcgi/4116257/img/3961366"); background-attachment: scroll; background-size: initial; background-origin: initial; background-clip: initial; background-position: 0px 0px; background-repeat: no-repeat;">Share on Facebook</button>
- <button data-share="Twitter" title="Share on Twitter" class="share_twitter" ref="id=16409223&db=pubmed" style="font-family: inherit; font-size: 13px; margin: 2px 2px 2px 0em; cursor: pointer; border: 0px none; height: 16px; padding: 2px; text-indent: -999em; width: 16px; opacity: 0.5; transition: opacity 0.2s linear 0s; background-image: url("//static.pubmed.gov/portal/portal3rc.fcgi/4116257/img/3961366"); background-attachment: scroll; background-size: initial; background-origin: initial; background-clip: initial; background-position: 0px -19px; background-repeat: no-repeat;">Share on Twitter</button>
- <button data-share="Google" title="Share on Google+" class="share_google" ref="id=16409223&db=pubmed" style="font-family: inherit; font-size: 13px; margin: 2px 2px 2px 0em; cursor: pointer; border: 0px none; height: 16px; padding: 2px; text-indent: -999em; width: 16px; opacity: 0.5; transition: opacity 0.2s linear 0s; background-image: url("//static.pubmed.gov/portal/portal3rc.fcgi/4116257/img/3961366"); background-attachment: scroll; background-size: initial; background-origin: initial; background-clip: initial; background-position: 0px -38px; background-repeat: no-repeat;">Share on Google+</button>
